Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Methylphenidate 18mg modified-release tablets |
| BNF code | 0404000M0AAAMAM |
| Virtual Therapeutic Moiety | Methylphenidate |
| Date identifier became valid | 5 Nov 2018 |
| Previous product identifier | 407881003 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Caution - AMP level prescribing advised |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Methylphenidate hydrochloride |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 18.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tabletmodified-release.oral |
| Dose Form | |
| Formulation | Modified-release tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | Schedule 2 (CD) |
| Actual Medicinal Products | |
| Affenid XL 18mg tablets (Zentiva Pharma UK Ltd) | |
| Concerta XL 18mg tablets (CST Pharma Ltd) | |
| Concerta XL 18mg tablets (Janssen-Cilag Ltd) | |
| Concerta XL 18mg tablets (Pilsco Ltd) | |
| Delmosart 18mg modified-release tablets (Accord-UK Ltd) | |
| Matoride XL 18mg tablets (Sandoz Ltd) | |
| Xaggitin XL 18mg tablets (Ethypharm UK Ltd) | |
| Xenidate XL 18mg tablets (Viatris UK Healthcare Ltd) | |
| Virtual Medicinal Product Packs | |
| Methylphenidate 18mg modified-release tablets 28 tablet | |
| Methylphenidate 18mg modified-release tablets 30 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.